Clinical trial Recruiting at 1 site Observational Ages 14 to 26

Evaluating return to play after ACL surgery with specific treatments

Official title: Return to Play After Anterior Cruciate Ligament Reconstruction With Bone Marrow Aspirate, Demineralized Bone Matrix, and an Internal Brace

Run by Marshall University · NCT06294314 · Data updated 2026-11-12

This study is testing how different treatments after ACL surgery affect young athletes' chances of getting back to their sport.

Quick facts

Study typeObservational
Ages14 Years to 26 Years
SexAll
Enrollment450 (estimated)
SponsorMarshall University
Academic / other
Locations1 site (Huntington, West Virginia)
StatusRecruiting
StartedFebruary 26, 2024
Main results expectedAugust 1, 2026
Study endsJuly 1, 2028
Registry record updatedMarch 5, 2024
Trial IDNCT06294314 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are skeletally mature individuals aged 14-26 with an ACL deficient knee seeking reconstructive surgery.

Probably not a fit

Patients requiring multi-ligament surgeries or those who have previously undergone ACL reconstruction may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of ACL reconstruction on athletes' ability to return to play by collecting various outcome measures and biomechanical data. Participants aged 14-26 who are undergoing ACL surgery will provide baseline information and undergo evaluations at multiple time points post-surgery. The study will assess factors such as graft type, surgical complications, and costs associated with the procedure. Additionally, MRI scans will be conducted at six months to evaluate bone healing.

Why it matters

Potential benefit: If successful, this study could enhance recovery protocols and improve return-to-play rates for young athletes after ACL reconstruction.

How similar studies have gone: While similar studies have explored ACL reconstruction outcomes, this specific approach with bone marrow aspirate and internal brace is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* INCLUSION CRITERIA: All patients must meet the following criteria:

  * Patients must be age 14-26 years old.
  * Skeletally mature patients, with an ACL deficient knee who desire to have ACL reconstructive surgery using autograft augmentation.
  * Patients must be a tanner stage of 5 and a posteroanterior left hand film x-ray will be obtained to confirm bone age and skeletal maturity
  * Patients with associated meniscal and chondral pathology (except patients falling into exclusion criteria below) will be included in the study; such pathology will be treated at the time of ACL reconstruction at the discretion of the surgeon, and such pathology and treatment will be recorded.
  * An understanding of the purpose of the study and providing written informed consent.

Exclusion Criteria:

* EXCLUSION CRITERIA:

  * Patients with multi-ligament surgery (MCL, PCL, LCL, PMC, or PLC repair or reconstruction),
  * Patients who have undergone previous ACL reconstructive surgery.
  * Patients who are currently pregnant or nursing.
  * Patients who have a current infection at the operative site.
  * Any condition or personal issue that the surgeon deems ineffective to the outcome of the study.

Where it's running

  • Marshall University
    Huntington, West Virginia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.